7 Results

People

  1. Berger
    Berger
  2. Capanu
    Capanu
  3. Chou
    Chou
  4. Ilson
    Ilson
  5. Janjigian
    Janjigian
  6. O'Reilly
    O'Reilly
  7. Solit
    Solit
  8. Tang
    Tang
  9. Desai
    Desai
  10. Goldberg
    Goldberg

Groups

  1. Biostatistics Service (7)
  2. Center for Pancreatic Cancer Research (7)
  3. Department of Medicine (7)
  4. Epidemiology and Biostatistics (7)
  5. GSK Faculty (7)
  6. Gastrointestinal Oncology Service (7)
  7. Human Oncology and Pathogenesis Program (7)
  8. Solid Tumor Oncology Division (7)
  9. Survivorship Research (5)
  10. Body Imaging Service (3)
  1. "male"
  2. "Michael Berger"
  3. "Marinela Capanu"
Formats
  1. Journal Article (7)
Groups
  1. Biostatistics Service (7)
  2. Center for Pancreatic Cancer Research (7)
  3. Department of Medicine (7)
  4. Epidemiology and Biostatistics (7)
  5. GSK Faculty (7)
  6. Gastrointestinal Oncology Service (7)

More Groups

People
  1. Marinela Capanu (7)
  2. Michael Berger (7)
  3. Joanne Chou (4)
  4. Laura Tang (4)
  5. Yelena Janjigian (4)
  6. David Ilson (3)

More People

Years
  1. 2023 (2)
  2. 2020 (2)
  3. 2018 (1)
  4. 2015 (2)
Publications
  1. Journal of Clinical Oncology (2)
  2. Annals of Surgical Oncology (1)
  3. Clinical Cancer Research (1)
  4. Lancet Oncology (1)
  5. PLoS ONE (1)
  6. The Oncologist (1)
Publishers
  1. American Society of Clinical Oncology (2)
  2. American Association for Cancer Research (1)
  3. Elsevier Science, Inc. (1)
  4. Oxford University Press (1)
  5. Public Library of Science (1)
  6. Springer (1)

Results (7)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Genomic profiling reveals germline predisposition and homologous recombination deficiency in pancreatic acinar cell carcinoma
    Journal Article

    Mandelker, D.; Marra, A.; Zheng-Lin, B.; Selenica, P.; Blanco-Heredia, J.; Zhu, Y.; Gazzo, A.; Wong, D.; Yelskaya, Z.; Rai, V.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • First-line regorafenib with nivolumab and chemotherapy in advanced oesophageal, gastric, or gastro-oesophageal junction cancer in the USA: A single-arm, single-centre, phase 2 trial
    Journal Article

    Cytryn, S. L.; Moy, R. H.; Cowzer, D.; Shah, R. H.; Chou, J. F.; Joshi, S. S.; Ku, G. Y.; Maron, S. B.; Desai, A.; Yang, J.; more...
    Lancet Oncology (2023)

    Fulltext@MSK | Save
  • Regorafenib in combination with first-line chemotherapy for metastatic esophagogastric cancer
    Journal Article

    Moy, R. H.; Dos Santos Fernandes, G.; Jonsson, P.; Chou, J. F.; Basunia, A.; Ku, G. Y.; Chalasani, S. B.; Boyar, M. S.; Goldberg, Z.; Desai, A. M.; more...
    The Oncologist (2020)

    Fulltext@MSK | Save
  • PD-1 blockade in advanced adrenocortical carcinoma
    Journal Article

    Raj, N.; Zheng, Y.; Kelly, V.; Katz, S. S.; Chou, J.; Do, R. K. G.; Capanu, M.; Zamarin, D.; Saltz, L. B.; Ariyan, C. E.; more...
    Journal of Clinical Oncology (2020)

    Fulltext@MSK | Save
  • Rates of TP53 mutation are significantly elevated in African American patients with gastric cancer
    Journal Article

    van Beek, E. J. A. H.; Hernandez, J. M.; Goldman, D. A.; Davis, J. L.; McLoughlin, K.; Ripley, R. T.; Kim, T. S.; Tang, L. H.; Hechtman, J. F.; Zheng, J.; more...
    Annals of Surgical Oncology (2018)

    Fulltext@MSK | Save
  • Phase II trial of sorafenib in patients with chemotherapy refractory metastatic esophageal and gastroesophageal (GE) junction cancer
    Journal Article

    Janjigian, Y. Y.; Vakiani, E.; Ku, G. Y.; Herrera, J. M.; Tang, L. H.; Bouvier, N.; Viale, A.; Socci, N. D.; Capanu, M.; Berger, M.; more...
    PLoS ONE (2015)

    Fulltext@MSK | Save
  • Pilot trial of combined BRAF and EGFR inhibition in BRAF-mutant metastatic colorectal cancer patients
    Journal Article

    Yaeger, R.; Cercek, A.; O'Reilly, E. M.; Reidy, D. L.; Kemeny, N.; Wolinsky, T.; Capanu, M.; Gollub, M. J.; Rosen, N.; Berger, M. F.; more...
    Clinical Cancer Research (2015)

    Fulltext@MSK | Save